XML 131 R119.htm IDEA: XBRL DOCUMENT v3.5.0.2
Guarantor Financial Information ( Condensed Consolidated Statement of Income) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Revenues [Abstract]                      
Product sales                 $ 6,099.9 $ 5,830.4 $ 4,757.5
Royalties and other revenues                 316.8 191.7 176.8
Total revenues $ 1,715.7 $ 1,655.0 $ 1,557.6 $ 1,488.4 $ 1,576.1 $ 1,597.1 $ 1,502.1 $ 1,346.8 6,416.7 6,022.1 4,934.3
Costs and Expenses [Abstract]                      
Cost of product sales 250.5 262.7 228.0 227.8 218.5 254.3 277.0 229.5 969.0 979.3 670.8
Research and Development Expense [1]                 1,564.0 1,067.5 933.4
Selling, General and Administrative Expense                 1,842.5 1,782.0 1,499.3
Integration and acquisition costs                 39.8 158.8 (134.1)
Amortization of acquired intangibles                 498.7 243.8 152.0
Total operating expenses                 4,997.2 4,324.1 3,200.8
Operating income/(loss) from continuing operations                 1,419.5 1,698.0 1,733.5
Other income/(expense), net                 3.7 8.9 (3.9)
Receipt of break fee                   1,635.4  
Income/(loss) from continuing operations before income taxes and equity in earnings/(losses) of equity method investees                 1,385.8 3,336.2 1,693.6
Income taxes                 (46.1) (56.1) (277.9)
Equity in losses/(earnings) of equity method investees                 2.2 (2.7) (3.9)
Income/(loss) from continuing operations, net of taxes 283.4 477.1 164.1 412.9 1,985.6 515.8 528.3 253.1 1,337.5 3,282.8 1,419.6
(Loss)/gain from discontinued operations, net of taxes (2.8) (24.3) (4.5) (2.5) 186.7 (36.1) (5.2) (22.7) (34.1) 122.7 (754.5)
Net income $ 280.6 $ 452.8 $ 159.6 $ 410.4 $ 2,172.3 $ 479.7 $ 523.1 $ 230.4 1,303.4 3,405.5 665.1
Comprehensive (loss)/income                 1,151.1 3,263.8 688.4
Consolidation, Eliminations [Member]                      
Revenues [Abstract]                      
Product sales                 0.0 0.0 0.0
Royalties and other revenues                 0.0 0.0 0.0
Total revenues                 0.0 0.0 0.0
Costs and Expenses [Abstract]                      
Cost of product sales                 0.0 0.0 0.0
Research and Development Expense                 0.0 0.0 0.0
Selling, General and Administrative Expense                 1.4 1.4 (0.2)
Integration and acquisition costs                 0.0 0.0 0.0
Amortization of acquired intangibles                 0.0 0.0 0.0
Other operating expenses                 0.0 0.0 0.0
Total operating expenses                 1.4 1.4 (0.2)
Operating income/(loss) from continuing operations                 (1.4) (1.4) 0.2
Interest (expense)/income,net                 0.0 0.0 0.0
Other income/(expense), net                 0.0 0.0 0.0
Receipt of break fee                   0.0  
Total other income/(expense), net                 0.0 0.0 0.0
Income/(loss) from continuing operations before income taxes and equity in earnings/(losses) of equity method investees                 (1.4) (1.4) 0.2
Income taxes                 0.0 0.0 0.0
Equity in losses/(earnings) of equity method investees                 1,388.1 1,919.8 729.7
Income/(loss) from continuing operations, net of taxes                 (1,389.5) (1,921.2) (729.5)
(Loss)/gain from discontinued operations, net of taxes                 0.0 0.0 0.0
Net income                 (1,389.5) (1,921.2) (729.5)
Comprehensive (loss)/income                 (1,237.2) (1,779.5) (752.8)
Consolidated                      
Revenues [Abstract]                      
Product sales                 6,099.9 5,830.4 4,757.5
Royalties and other revenues                 316.8 191.7 176.8
Total revenues                 6,416.7 6,022.1 4,934.3
Costs and Expenses [Abstract]                      
Cost of product sales                 969.0 979.3 670.8
Research and Development Expense                 1,564.0 1,067.5 933.4
Selling, General and Administrative Expense                 1,842.5 1,782.0 1,499.3
Integration and acquisition costs                 39.8 158.8 (134.1)
Amortization of acquired intangibles                 498.7 243.8 152.0
Other operating expenses                 83.2 92.7 79.4
Total operating expenses                 4,997.2 4,324.1 3,200.8
Operating income/(loss) from continuing operations                 1,419.5 1,698.0 1,733.5
Interest (expense)/income,net                 (37.4) (6.1) (36.0)
Other income/(expense), net                 3.7 8.9 (3.9)
Receipt of break fee                   1,635.4  
Total other income/(expense), net                 (33.7) 1,638.2 (39.9)
Income/(loss) from continuing operations before income taxes and equity in earnings/(losses) of equity method investees                 1,385.8 3,336.2 1,693.6
Income taxes                 46.1 56.1 277.9
Equity in losses/(earnings) of equity method investees                 2.2 (2.7) (3.9)
Income/(loss) from continuing operations, net of taxes                 1,337.5 3,282.8 1,419.6
(Loss)/gain from discontinued operations, net of taxes                 (34.1) 122.7 (754.5)
Net income                 1,303.4 3,405.5 665.1
Comprehensive (loss)/income                 1,151.1 3,263.8 688.4
Shire Plc ( Parent Guarantor)                      
Revenues [Abstract]                      
Product sales                 0.0 0.0 0.0
Royalties and other revenues                 0.0 0.0 0.0
Total revenues                 0.0 0.0 0.0
Costs and Expenses [Abstract]                      
Cost of product sales                 0.0 0.0 0.0
Research and Development Expense                 0.0 0.0 0.0
Selling, General and Administrative Expense                 24.9 109.4 26.6
Integration and acquisition costs                 0.0 0.0 0.0
Amortization of acquired intangibles                 0.0 0.0 0.0
Other operating expenses                 0.0 0.0 0.0
Total operating expenses                 24.9 109.4 26.6
Operating income/(loss) from continuing operations                 (24.9) (109.4) (26.6)
Interest (expense)/income,net                 (63.6) (42.8) (38.8)
Other income/(expense), net                 0.9 0.3 0.2
Receipt of break fee                   1,635.4  
Total other income/(expense), net                 (62.7) 1,592.9 (38.6)
Income/(loss) from continuing operations before income taxes and equity in earnings/(losses) of equity method investees                 (87.6) 1,483.5 (65.2)
Income taxes                 (2.9) (2.2) (0.6)
Equity in losses/(earnings) of equity method investees                 (1,388.1) (1,919.8) (729.7)
Income/(loss) from continuing operations, net of taxes                 1,303.4 3,405.5 665.1
(Loss)/gain from discontinued operations, net of taxes                 0.0 0.0 0.0
Net income                 1,303.4 3,405.5 665.1
Comprehensive (loss)/income                 1,151.1 3,263.8 688.4
SAIIDAC ( Subsidiary issuer)                      
Revenues [Abstract]                      
Product sales                 0.0 0.0 0.0
Royalties and other revenues                 0.0 0.0 0.0
Total revenues                 0.0 0.0 0.0
Costs and Expenses [Abstract]                      
Cost of product sales                 0.0 0.0 0.0
Research and Development Expense                 0.0 0.0 0.0
Selling, General and Administrative Expense                 0.0 0.0 0.0
Integration and acquisition costs                 0.0 0.0 0.0
Amortization of acquired intangibles                 0.0 0.0 0.0
Other operating expenses                 0.0 0.0 0.0
Total operating expenses                 0.0 0.0 0.0
Operating income/(loss) from continuing operations                 0.0 0.0 0.0
Interest (expense)/income,net                 (1.7) 0.0 0.0
Other income/(expense), net                 0.0 0.0 0.0
Receipt of break fee                   0.0  
Total other income/(expense), net                 (1.7) 0.0 0.0
Income/(loss) from continuing operations before income taxes and equity in earnings/(losses) of equity method investees                 (1.7) 0.0 0.0
Income taxes                 0.0 0.0 0.0
Equity in losses/(earnings) of equity method investees                 0.0 0.0 0.0
Income/(loss) from continuing operations, net of taxes                 (1.7) 0.0 0.0
(Loss)/gain from discontinued operations, net of taxes                 0.0 0.0 0.0
Net income                 (1.7) 0.0 0.0
Comprehensive (loss)/income                 (1.7) 0.0 0.0
Baxalta (Subsidiary Issuer)                      
Revenues [Abstract]                      
Product sales                 0.0 0.0 0.0
Royalties and other revenues                 0.0 0.0 0.0
Total revenues                 0.0 0.0 0.0
Costs and Expenses [Abstract]                      
Cost of product sales                 0.0 0.0 0.0
Research and Development Expense                 0.0 0.0 0.0
Selling, General and Administrative Expense                 0.0 0.0 0.0
Integration and acquisition costs                 0.0 0.0 0.0
Amortization of acquired intangibles                 0.0 0.0 0.0
Other operating expenses                 0.0 0.0 0.0
Total operating expenses                 0.0 0.0 0.0
Operating income/(loss) from continuing operations                 0.0 0.0 0.0
Interest (expense)/income,net                 0.0 0.0 0.0
Other income/(expense), net                 0.0 0.0 0.0
Receipt of break fee                   0.0  
Total other income/(expense), net                 0.0 0.0 0.0
Income/(loss) from continuing operations before income taxes and equity in earnings/(losses) of equity method investees                 0.0 0.0 0.0
Income taxes                 0.0 0.0 0.0
Equity in losses/(earnings) of equity method investees                 0.0 0.0 0.0
Income/(loss) from continuing operations, net of taxes                 0.0 0.0 0.0
(Loss)/gain from discontinued operations, net of taxes                 0.0 0.0 0.0
Net income                 0.0 0.0 0.0
Comprehensive (loss)/income                 0.0 0.0 0.0
Non-Guarantor Non-Issuer Subsidiaries                      
Revenues [Abstract]                      
Product sales                 6,099.9 5,830.4 4,757.5
Royalties and other revenues                 316.8 191.7 176.8
Total revenues                 6,416.7 6,022.1 4,934.3
Costs and Expenses [Abstract]                      
Cost of product sales                 969.0 979.3 670.8
Research and Development Expense                 1,564.0 1,067.5 933.4
Selling, General and Administrative Expense                 1,816.2 1,671.2 1,472.9
Integration and acquisition costs                 39.8 158.8 (134.1)
Amortization of acquired intangibles                 498.7 243.8 152.0
Other operating expenses                 83.2 92.7 79.4
Total operating expenses                 4,970.9 4,213.3 3,174.4
Operating income/(loss) from continuing operations                 1,445.8 1,808.8 1,759.9
Interest (expense)/income,net                 27.9 36.7 2.8
Other income/(expense), net                 2.8 8.6 (4.1)
Receipt of break fee                   0.0  
Total other income/(expense), net                 30.7 45.3 (1.3)
Income/(loss) from continuing operations before income taxes and equity in earnings/(losses) of equity method investees                 1,476.5 1,854.1 1,758.6
Income taxes                 49.0 58.3 278.5
Equity in losses/(earnings) of equity method investees                 2.2 (2.7) (3.9)
Income/(loss) from continuing operations, net of taxes                 1,425.3 1,798.5 1,484.0
(Loss)/gain from discontinued operations, net of taxes                 (34.1) 122.7 (754.5)
Net income                 1,391.2 1,921.2 729.5
Comprehensive (loss)/income                 1,238.9 1,779.5 752.8
Non-Guarantor Subsidiaries of SAIIDAC                      
Revenues [Abstract]                      
Product sales                 6,099.9 5,830.4 4,757.5
Royalties and other revenues                 316.8 191.7 176.8
Total revenues                 6,416.7 6,022.1 4,934.3
Costs and Expenses [Abstract]                      
Cost of product sales                 969.0 979.3 670.8
Research and Development Expense                 1,564.0 1,067.5 933.4
Selling, General and Administrative Expense                 1,816.2 1,671.2 1,472.9
Integration and acquisition costs                 39.8 158.8 (134.1)
Amortization of acquired intangibles                 498.7 243.8 152.0
Other operating expenses                 83.2 92.7 79.4
Total operating expenses                 4,970.9 4,213.3 3,174.4
Operating income/(loss) from continuing operations                 1,445.8 1,808.8 1,759.9
Interest (expense)/income,net                 27.9 36.7 2.8
Other income/(expense), net                 2.8 8.6 (4.1)
Receipt of break fee                   0.0  
Total other income/(expense), net                 30.7 45.3 (1.3)
Income/(loss) from continuing operations before income taxes and equity in earnings/(losses) of equity method investees                 1,476.5 1,854.1 1,758.6
Income taxes                 49.0 58.3 278.5
Equity in losses/(earnings) of equity method investees                 2.2 (2.7) (3.9)
Income/(loss) from continuing operations, net of taxes                 1,425.3 1,798.5 1,484.0
(Loss)/gain from discontinued operations, net of taxes                 (34.1) 122.7 (754.5)
Net income                 1,391.2 1,921.2 729.5
Comprehensive (loss)/income                 1,238.9 1,779.5 752.8
Non-Guarantor Subsidiaries of Baxalta                      
Revenues [Abstract]                      
Product sales                 6,099.9 5,830.4 4,757.5
Royalties and other revenues                 316.8 191.7 176.8
Total revenues                 6,416.7 6,022.1 4,934.3
Costs and Expenses [Abstract]                      
Cost of product sales                 969.0 979.3 670.8
Research and Development Expense                 1,564.0 1,067.5 933.4
Selling, General and Administrative Expense                 1,816.2 1,671.2 1,472.9
Integration and acquisition costs                 39.8 158.8 (134.1)
Amortization of acquired intangibles                 498.7 243.8 152.0
Other operating expenses                 83.2 92.7 79.4
Total operating expenses                 4,970.9 4,213.3 3,174.4
Operating income/(loss) from continuing operations                 1,445.8 1,808.0 1,759.9
Interest (expense)/income,net                 26.2 36.7 2.8
Other income/(expense), net                 2.8 8.6 (4.1)
Receipt of break fee                   0.0  
Total other income/(expense), net                 29.0 45.3 (1.3)
Income/(loss) from continuing operations before income taxes and equity in earnings/(losses) of equity method investees                 1,474.8 1,854.1 1,758.6
Income taxes                 49.0 58.3 278.5
Equity in losses/(earnings) of equity method investees                 2.2 (2.7) (3.9)
Income/(loss) from continuing operations, net of taxes                 1,423.6 1,798.5 1,484.0
(Loss)/gain from discontinued operations, net of taxes                 (34.1) 122.7 (754.5)
Net income                 1,389.5 1,921.2 729.5
Comprehensive (loss)/income                 $ 1,237.2 $ 1,779.5 $ 752.8
[1] Research and development (“R&D”) includes IPR&D intangible asset impairment charges of $643.7 million for the year to December 31, 2015 (2014: $190.3 million, 2013: $19.9 million)..